(Q38263685)

1 September 2017

title

Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy (English)

1 reference

1 September 2017

0 references

Jin-Tai Yu

2

0 references

Lan Tan

series ordinal

3

object named as

Lan Tan

1 reference

1 September 2017

1

Jing-Hui Song

1 reference

1 September 2017

publication date

30 October 2014

1 reference

1 September 2017

published in

Molecular Neurobiology

1 reference

1 September 2017

volume

52

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

1477-1493

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-014-8958-4

1 September 2017

exact match

0 references

cites work

NGF, BDNF, NT3, and NT4.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF and synaptic plasticity, cognitive function, and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Serum brain-derived neurotrophic factor levels in different neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor gene variants and Alzheimer disease: an association study in an Alzheimer disease Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

A network map of BDNF/TRKB and BDNF/p75NTR signaling system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The cholinergic system in aging and neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Enhancing Diagnostic Accuracy of aMCI in the Elderly: Combination of Olfactory Test, Pupillary Response Test, BDNF Plasma Level, and APOE Genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The associations between serum brain-derived neurotrophic factor, potential confounders, and cognitive decline: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Steroid hormones and BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The impact of age, weight and gender on BDNF levels in human platelets and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Blood BDNF concentrations reflect brain-tissue BDNF levels across species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Rutin activates the MAPK pathway and BDNF gene expression on beta-amyloid induced neurotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer m

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

β-Amyloid impairs axonal BDNF retrograde trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Alzheimer's disease: synaptic dysfunction and Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Gene expression in the conversion of early-phase to late-phase long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Essential role of brain-derived neurotrophic factor in adult hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Does lithium prevent Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neotrofin reverses the effects of chronic unpredictable mild stress on behavior via regulating BDNF, PSD-95 and synaptophysin expression in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Ethanolic Extract of the Seed of Zizyphus jujuba var. spinosa Ameliorates Cognitive Impairment Induced by Cholinergic Blockade in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Exogenous T3 administration provides neuroprotection in a murine model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Epigenetic inheritance of a cocaine-resistance phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Long-term exercise modulates hippocampal gene expression in senescent female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Determinants of serum brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Acupuncture stimulation induces neurogenesis in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Region-Specific Neurotrophin Imbalances in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8958-4

Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Neurotrophins and synaptic plasticity

1 reference

12 December 2020

Brain-derived neurotrophic factor levels in Alzheimer's disease

1 reference

12 December 2020

Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?

1 reference

12 December 2020

The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits

1 reference

12 December 2020

[Effects of icariin on beta-amyloid and neurotrophic factors in brain of mitochondrial deficiency model rats].

1 reference

12 December 2020

Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells

1 reference

12 December 2020

Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression.

1 reference

12 December 2020

Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia

1 reference

12 December 2020

[Brain-derived neurotrophic factor prevents against amyloid beta protein-induced impairment of hippocampal in vivo long-term potentiation in rats].

1 reference

12 December 2020

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.

1 reference

12 December 2020

Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

1 reference

12 December 2020

Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice

1 reference

12 December 2020

Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume

1 reference

12 December 2020

Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease.

1 reference

12 December 2020

Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.

1 reference

12 December 2020

The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus

1 reference

12 December 2020

10.1007/S12035-014-8958-4

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1041581955

0 references

1 reference